Gts Securities LLC Astrazeneca PLC Call Options Transaction History

Gts Securities LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $855,168 - $1.03 Million	12,800 Added 28.01%	58,500 $4.56 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $1.92 Million - $2.18 Million	-31,400 Reduced 40.73%	45,700 $3.1 Million
Q4 2023 Feb 14, 2024	SELL	$61.89 - $69.28 $1.99 Million - $2.22 Million	-32,100 Reduced 29.4%	77,100 $5.19 Million
Q3 2023 Nov 15, 2023	BUY	$64.85 - $71.7 $7.08 Million - $7.83 Million	109,200 New	109,200 $7.4 Million

1,333

490M

4.99M

3.19M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $241B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Gts Securities LLC with notifications on news.